We are excited to announce a new partnership with Newcastle MRC Molecular Pathology Node and Dr. Alastair Burt who is a leading expert in liver fibrosis. This partnership will combine the histopathology expertise from Dr. Burt and the Newcastle node along with the novel CHPs developed by 3Helix to investigate liver fibrosis. The goal of this collaboration will be to first establish CHPs as a reliable stain for evaluating fibrotic progression in liver disease to replace existing histochemical approaches such as trichrome staining or Picrosirius Red. Second, we hope to provide additional clinically important information that will aid clinicians in the decision-making process for patient care. Check out their site here: http://www.newcastlepathnode.org.uk/about/newcastle-pathology-node/

Leave a Reply

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know!